Compare LACTOSE INDIA with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LACTOSE INDIA vs BETA DRUGS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    LACTOSE INDIA BETA DRUGS LACTOSE INDIA/
BETA DRUGS
 
P/E (TTM) x -117.9 - - View Chart
P/BV x 1.8 8.5 21.3% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 LACTOSE INDIA   BETA DRUGS
EQUITY SHARE DATA
    LACTOSE INDIA
Mar-21
BETA DRUGS
Mar-21
LACTOSE INDIA/
BETA DRUGS
5-Yr Chart
Click to enlarge
High Rs42141 29.7%   
Low Rs1639 41.0%   
Sales per share (Unadj.) Rs30.6120.8 25.3%  
Earnings per share (Unadj.) Rs-2.212.2 -17.8%  
Cash flow per share (Unadj.) Rs1.619.4 8.5%  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs30.171.4 42.2%  
Shares outstanding (eoy) m11.449.61 119.0%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.90.7 126.9%   
Avg P/E ratio x-13.37.4 -180.8%  
P/CF ratio (eoy) x17.64.6 377.9%  
Price / Book Value ratio x1.01.3 76.0%  
Dividend payout %00-   
Avg Mkt Cap Rs m330864 38.2%   
No. of employees `000NANA-   
Total wages/salary Rs m10683 127.8%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m3501,161 30.1%  
Other income Rs m35 62.9%   
Total revenues Rs m3531,166 30.2%   
Gross profit Rs m62247 25.1%  
Depreciation Rs m4469 63.4%   
Interest Rs m5424 225.1%   
Profit before tax Rs m-33160 -20.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-842 -18.8%   
Profit after tax Rs m-25117 -21.1%  
Gross profit margin %17.821.3 83.5%  
Effective tax rate %24.226.5 91.5%   
Net profit margin %-7.110.1 -70.2%  
BALANCE SHEET DATA
Current assets Rs m197718 27.4%   
Current liabilities Rs m116376 30.9%   
Net working cap to sales %23.129.4 78.5%  
Current ratio x1.71.9 88.8%  
Inventory Days Days5917 339.0%  
Debtors Days Days671106,481,972 0.0%  
Net fixed assets Rs m686483 142.0%   
Share capital Rs m11496 119.0%   
"Free" reserves Rs m230590 39.1%   
Net worth Rs m345686 50.3%   
Long term debt Rs m393111 352.8%   
Total assets Rs m8831,201 73.5%  
Interest coverage x0.47.6 5.3%   
Debt to equity ratio x1.10.2 701.9%  
Sales to assets ratio x0.41.0 40.9%   
Return on assets %3.411.8 28.6%  
Return on equity %-7.217.1 -42.0%  
Return on capital %3.023.0 12.8%  
Exports to sales %010.2 0.0%   
Imports to sales %7.40-   
Exports (fob) Rs mNA118 0.0%   
Imports (cif) Rs m26NA-   
Fx inflow Rs m25118 20.7%   
Fx outflow Rs m273 1,040.6%   
Net fx Rs m-2116 -1.8%   
CASH FLOW
From Operations Rs m22186 11.6%  
From Investments Rs m-62-58 105.6%  
From Financial Activity Rs m45-77 -58.6%  
Net Cashflow Rs m550 10.2%  

Share Holding

Indian Promoters % 52.5 66.7 78.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.6 0.3 220.7%  
FIIs % 0.0 0.3 -  
ADR/GDR % 0.0 0.0 -  
Free float % 47.5 33.3 142.7%  
Shareholders   15,696 675 2,325.3%  
Pledged promoter(s) holding % 41.2 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare LACTOSE INDIA With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

Indian Indices End Flat Amid High Volatility; Maruti Suzuki & Tech Mahindra Among Top Losers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended marginally lower.

Related Views on News

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Demerger of Financial & Pharma Businesses puts Piramal Enterprises in Limelight (Views On News)

Oct 8, 2021

The company's shareholders will be issued 4 shares in the demerged entity for every 1 held in Piramal Enterprises.

More Views on News

Most Popular

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look?(Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

5 Hidden Tata Group Companies to Add to Your Watchlist(Views On News)

Jan 18, 2022

Here's all you need to know about these five Tata group stocks that aren't as popular as the others.

Insiders are Buying into these 6 Stocks Aggressively. More Details here...(Views On News)

Jan 19, 2022

While promoter holding is an important parameter, it should not be the sole reason for buying a stock.

Top Indian Drone Companies to Watch Out for in 2022(Views On News)

Jan 21, 2022

Several companies are adopting drone technology for regular business operations.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

LACTOSE INDIA SHARE PRICE


Jan 28, 2022 (Close)

TRACK LACTOSE INDIA

  • Track your investment in LACTOSE INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

LACTOSE INDIA - ZANDU REALTY COMPARISON

COMPARE LACTOSE INDIA WITH

MARKET STATS